There’s a new twist in the fight against bladder cancer — and it’s delivering game-changing results. In a recent clinical ...

A research team co-led by UCLA investigators has found that pembrolizumab, an immunotherapy drug that helps the immune system ...

Programmed death-1 (PD-1) inhibition with pembrolizumab led to durable remission in 31.3% of patients with early acute ...

Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Eli Lilly and Company, in collaboration ...

In August 2025, Seagen announced a studies how well tucatinib works for solid tumors that make either more HER2 or a ...

The field of genitourinary (GU) oncology has seen significant developments over recent decades, yet challenges in treatment outcomes remain. Current ...